Overview
American Vanguard Q3 revenue missed analyst expectations, net income also missed
Adjusted EBITDA for Q3 rises to $8.2 mln from $1.8 mln last year
Company maintains full-year 2025 EBITDA guidance of $40 mln to $44 mln
Outlook
American Vanguard maintains 2025 adjusted EBITDA guidance of $40 mln to $44 mln
Company expects greater market stability as it heads into 2026
Fourth quarter expected to be strongest, generating material free cash flow
Result Drivers
MANUFACTURING EFFICIENCY - Improved manufacturing efficiency contributed to higher gross profit margins and increased EBITDA
INVENTORY REDUCTION - Reduction in total inventory by $47 mln limited the need to access credit
PRODUCT LIABILITY CHARGE - $7.6 mln charge for product liability claims included in adjusted EBITDA, with future recovery expected
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
Miss
$119.31 mln
$128 mln (1 Analyst)
Q3 Net Income
Miss
-$12.36 mln
-$2.35 mln (1 Analyst)
Q3 Operating Income
Miss
-$6.51 mln
$1.12 mln (1 Analyst)
Q3 Gross Profit
$34.21 mln
Analyst Coverage
The one available analyst rating on the shares is "buy"
The average consensus recommendation for the agricultural chemicals peer group is "buy"
Wall Street's median 12-month price target for American Vanguard Corp is $12.00, about 57.5% above its November 7 closing price of $5.10
The stock recently traded at 23 times the next 12-month earnings vs. a P/E of 21 three months ago
Press Release: ID:nACSwMLWza
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)